Preclinical proof of principle for orally delivered Th17 antagonist miniproteins
Cell,
De novo proteins can be computationally designed with sub-picomolar affinity and extreme stability to enable oral…
De novo proteins can be computationally designed with sub-picomolar affinity and extreme stability to enable oral…
L'ustekinumab, un anticorpo monoclonale sviluppato dalla casa farmaceutica belga Janssen, ha dimostrato un'azione rapida e…
By Maria Sunseri…
A study has found a potential new treatment option for those suffering from Crohn's and other bowel diseases.